Literature DB >> 18641362

Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

Nigel D L Savage1, Tjitske de Boer, Kimberley V Walburg, Simone A Joosten, Krista van Meijgaarden, Annemiek Geluk, Tom H M Ottenhoff.   

Abstract

CD4(+) T cell differentiation and function are critically dependent on the type of APC and the microenvironment in which Ag presentation occurs. Most studies have documented the effect of dendritic cells on effector and regulatory T cell differentiation; however, macrophages are the most abundant APCs in the periphery and can be found in virtually all organs and tissues. The effect of macrophages, and in particular their subsets, on T cell function has received little attention. Previously, we described distinct subsets of human macrophages (pro- and anti-inflammatory, m phi1 and m phi2, respectively) with highly divergent cell surface Ag expression and cytokine/chemokine production. We reported that human m phi1 promote, whereas m phi2 decrease, Th1 activation. Here, we demonstrate that m phi2, but not m phi1, induce regulatory T cells with a strong suppressive phenotype (T(m phi2)). Their mechanism of suppression is cell-cell contact dependent, mediated by membrane-bound TGFbeta-1 expressed on the regulatory T cell (Treg) population since inhibition of TGFbeta-1 signaling in target cells blocks the regulatory phenotype. T(m phi2), in addition to mediating cell-cell contact-dependent suppression, express typical Treg markers such as CD25, glucocorticoid-induced TNF receptor (GITR), and Foxp3 and are actively induced by m phi2 from CD25-depleted cells. These data identify m phi2 cells as a novel APC subset capable of inducing Tregs. The ability of anti-inflammatory macrophages to induce Tregs in the periphery has important implications for understanding Treg dynamics in pathological conditions where macrophages play a key role in inflammatory disease control and exacerbation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641362     DOI: 10.4049/jimmunol.181.3.2220

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  115 in total

Review 1.  Immunologic mechanisms in RCC and allogeneic renal transplant rejection.

Authors:  Jens Bedke; Arnulf Stenzl
Journal:  Nat Rev Urol       Date:  2010-05-11       Impact factor: 14.432

2.  CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice.

Authors:  Christian Weber; Svenja Meiler; Yvonne Döring; Miriam Koch; Maik Drechsler; Remco T A Megens; Zuzanna Rowinska; Kiril Bidzhekov; Caroline Fecher; Eliana Ribechini; Marc A M J van Zandvoort; Christoph J Binder; Ivett Jelinek; Mihail Hristov; Louis Boon; Steffen Jung; Thomas Korn; Manfred B Lutz; Irmgard Förster; Martin Zenke; Thomas Hieronymus; Tobias Junt; Alma Zernecke
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

Review 3.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

4.  Transplant tolerance: a new role for IL-34.

Authors:  James I Kim; Laurence A Turka
Journal:  J Clin Invest       Date:  2015-09-21       Impact factor: 14.808

Review 5.  Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.

Authors:  Weihua Zhao; David R Beers; Stanley H Appel
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

Review 6.  T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Authors:  Stanley H Appel; David R Beers; Jenny S Henkel
Journal:  Trends Immunol       Date:  2009-10-31       Impact factor: 16.687

Review 7.  The heterogenic properties of monocytes/macrophages and neutrophils in inflammatory response in diabetes.

Authors:  Xiaoquan Rao; Jixin Zhong; Qinghua Sun
Journal:  Life Sci       Date:  2014-09-28       Impact factor: 5.037

8.  Growth hormone prevents the development of autoimmune diabetes.

Authors:  Ricardo Villares; Dimitri Kakabadse; Yasmina Juarranz; Rosa P Gomariz; Carlos Martínez-A; Mario Mellado
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

9.  FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development.

Authors:  Rizwanul Haque; Fengyang Lei; Xiaofang Xiong; Yuzhang Wu; Jianxun Song
Journal:  Arthritis Res Ther       Date:  2010-04-12       Impact factor: 5.156

10.  Maggot secretions skew monocyte-macrophage differentiation away from a pro-inflammatory to a pro-angiogenic type.

Authors:  Mariena J A van der Plas; Jaap T van Dissel; Peter H Nibbering
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.